# US 2023/0056514 A1 · Multi-Functional Cleaning and/or Debridement Composition

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0056514 A1
- Document ID: US20230056514A1
- Status: Published application
- Kind: A1
- Application number: 17/939,670
- Filed: 2022-09-07
- Published: 2023-02-23
- Earliest claimed: 2020-03-18
- Assignees: Corticalis AS
- Applicants: Corticalis AS
- Inventors: Ståle Petter Lyngstadaas; Håvard J. Haugen
- Web page: https://patentgrep.com/patent/US20230056514A1

## CPC

- A61K 33/40: Peroxides
- A61L 15/60: Liquid-swellable gel-forming materials, e.g. super-absorbents
- A01N 59/00: Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A61K 9/06: Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)}
- A61K 9/08: Solutions {(composition of solutions A61K47/00)}
- A61K 31/327: Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
- A61K 47/12: Carboxylic acids; Salts or anhydrides thereof
- A61K 47/34: Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers (A61K47/10 takes precedence)
- A61L 15/08: containing inorganic materials, e.g. plaster of Paris
- A61L 15/44: Medicaments
- A61L 26/0004: {containing inorganic materials}
- A61L 26/0066: {Medicaments; Biocides}
- A61L 26/008: {Hydrogels or hydrocolloids}
- A61L 26/0095: {Composite materials, i.e. containing one material dispersed in a matrix of the same or different material}
- A61P 31/04: Antibacterial agents
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to a new multifunctional debridement and/or antifouling composition comprising H2O2 at a final concentration of between 0.1-5% v/v, and a composite hydrogel formulation comprising pluronic acid at a concentration of 10-40% w/v, wherein the composition is in liquid form at room temperature. The composition disclosed herein is antimicrobial and/or anti-inflammatory and is particular useful in periimplantitis treatment and implant health maintenance, in periodontitis and periodontal health and in wound care and chronic ulcer care.

## Claims

### Claim 1

An antimicrobial and/or anti-inflammatory composition for cleaning and/or debriding a biological surface and/or a biomaterial surface in situ, comprising at least two components
a. H2O2 at a final concentration of between 0.1-5% v/v, and
b. a composite hydrogel formulation comprising pluronic acid at a concentration of 10-40% w/v,
wherein the composition is liquid at a temperature of at the most 30° Celsius.

### Claim 2 (depends on 1)

An antimicrobial and/or anti-inflammatory composition according to claim 1, wherein the at least two components
a. H2O2, and
b. a composite hydrogel formulation comprising pluronic acid,
are kept separate from each other until they are simultaneously mixed and applied to a biological surface and/or a biomaterial surface in situ.

### Claim 3 (depends on 1)

An antimicrobial and/or anti-inflammatory composition according to claim 1, wherein the separate component a. is a composition that comprises H2O2 at a concentration of at least 10-50% v/v.

### Claim 4 (depends on 1)

A composition according to claim 1, further comprising microparticles having a mean particle diameter (D50) of 20-200 μm, wherein said microparticles are organic or inorganic.

### Claim 5 (depends on 8)

A composition according to claim 8, wherein said microparticles are biodegradable.

### Claim 6 (depends on 1)

A composition according to claim 1, further comprising at least one mesh-forming and/or scaffolding component.

### Claim 7 (depends on 1)

A composition according to claim 1, further comprising a bioactive substance.

### Claim 8 (depends on 1)

A kit comprising a composition according to claim 1, the kit further comprising
h. at least two containers comprising said components a. and b., respectively,
i. a syringe and a vial,
j. a connector device,
k. an applicator tip, and
l. an instruction leaflet.

### Claim 9 (depends on 8)

A kit according to claim 8, further comprising
m. a mixing device and
n. a debridement tool.

### Claim 10 (depends on 1)

A kit comprising a composition according to claim 1, wherein said two components a. and b. are provided in a two-chamber syringe.

### Claim 11 (depends on 1)

A process for removal of biofouling, biofilm and/or necrotic tissue from a biological surface and/or a biomaterial surface in situ comprising the step of applying a composition according to claim 1 to the surface.

### Claim 12 (depends on 1)

A method for the treatment and/or prevention of periimplantitis, gingivitis, mucositis, peri-implant mucositis, periodontitis, and/or chronic and/or infected dermal ulcers comprising the step of applying a composition according to claim 1 to the tissue to be treated.
